BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 14, 2012
View Archived Issues
New potential antibodies for anticancer use developed in U.S.
Read More
Potent novel ALK inhibitors presented
Read More
New dual allosteric Akt inhibitors show promise in cancer models
Read More
Antiglaucoma agent ATS-8535 characterized in vitro and in vivo
Read More
Novel HealOr product accelerates corneal healing
Read More
CNK1 PH domain investigated as a target for KRas-mutant cancer
Read More
Mitsubishi Tanabe Pharma reviews highlights of fiscal 2011
Read More
Research in U.K. links SNP to systemic sclerosis risk
Read More
Japanese phase II study of ONO-2745 completed
Read More
FDA committee votes on approval of Quad regimen
Read More
Phytopharm reports on preclinical Myogane study
Read More
Depomed receives milestone payment from Ironwood Pharmaceuticals
Read More
Kancera compounds show promise in cancer treatment
Read More
Theratechnologies' TH-1173 enters preclinical safety phase
Read More
Arno Therapeutics product obtains orphan drug status for NF2
Read More
New data presented on brentuximab vedotin in cutaneous T-cell lymphoma
Read More
Proximagen designs novel chemokine CXCR4 receptor antagonists
Read More
Novel OSM-directed antibodies created at Janssen Biotech
Read More
AstraZeneca presents new transient receptor potential TRPA1 channel antagonists
Read More
Research at Amicus yields new pharmacological chaperones
Read More
Novel candidate drugs for Alzheimer's disease patented
Read More
Islet Sciences licenses technology from Yale University
Read More
Galapagos kicks off new study of novel JAK1 inhibitor
Read More
Health Canada grants Apricus Biosciences meeting for nail fungus therapy
Read More
Mologen study meets primary endpoint
Read More